Which NSAID regimen least costly for arthritis in Hong Kong?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.399, 2003-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alemtuzumab: a costly alternative in CLL?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Quality of Life in Patients with Rheumatoid Arthritis: Which Drugs Might Make a Difference?

By Blumenauer B.

PharmacoEconomics, Vol. 21, Iss. 13, 2003-01 ,pp. : 927-940

Adis International

Access to resources Recommend Favorite

By Graziano Onder Francesca Pellicciotti Giovanni Gambassi Roberto Bernabei

Drugs, Vol. 64, Iss. 23, 2004-01 ,pp. : 2619-2627

Adis International

Access to resources Recommend Favorite

NSAID chemoprevention warranted in Barrett's oesophagus?

Inpharma, Vol. 1, Iss. 1395, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Extraimmunisation in paediatric patients - costly shots?

Inpharma, Vol. 1, Iss. 1229, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite